<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04384679</url>
  </required_header>
  <id_info>
    <org_study_id>20-02021562</org_study_id>
    <nct_id>NCT04384679</nct_id>
  </id_info>
  <brief_title>Benefit of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery</brief_title>
  <official_title>The Evaluation of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Weill Medical College of Cornell University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the efficacy and safety of topical hemostatic powder
      containing hydrophilic polymer with potassium ferrate for bleeding control after nail
      surgical procedures
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2020</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time (in seconds) to bleeding cessation with hydrophilic polymer and potassium ferrate; time (in seconds) to bleeding cessation with direct pressure with sterile gauze</measure>
    <time_frame>Baseline</time_frame>
    <description>Time (in seconds) will be measured from application of intervention/nonintervention until bleeding cessation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with at least one adverse event</measure>
    <time_frame>End of study (28 days)</time_frame>
    <description>Adverse events will only include those that are determined to be related to the study device</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Nail Diseases</condition>
  <arm_group>
    <arm_group_label>Hydrophilic polymer and potassium ferrate powder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hydrophilic polymer with potassium ferrate powder is applied to the surgical wound with pressure until hemostasis is achieved</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Direct pressure with sterile gauze</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Direct pressure with sterile gauze is applied to the surgical wound until hemostasis is achieved</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hydrophilic polymer and potassium ferrate powder</intervention_name>
    <description>Application with pressure until hemostasis is achieved</description>
    <arm_group_label>Hydrophilic polymer and potassium ferrate powder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 18 years old

          -  Patients scheduled for any type of nail surgical procedure

          -  Willingness to participate in the study

          -  Ability to understand all instructions in the English language

        Exclusion Criteria:

          -  Failure to have nail surgery performed

          -  Likely inability to comply with the study protocol or cooperate fully with the
             research team
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shari R Lipner, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Medical College of Cornell University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jose W Ricardo, MD</last_name>
    <phone>9172937853</phone>
    <email>jwr4001@med.cornell.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Weill Cornell Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Shari R Lipner, MD, PhD</last_name>
      <phone>646-962-3376</phone>
      <email>shl9032@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Shari R Lipner, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 8, 2020</study_first_submitted>
  <study_first_submitted_qc>May 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2020</study_first_posted>
  <last_update_submitted>July 17, 2020</last_update_submitted>
  <last_update_submitted_qc>July 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nails</keyword>
  <keyword>Nail Surgery</keyword>
  <keyword>Hemostasis</keyword>
  <keyword>Potassium Ferrate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nail Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

